mRNA-Derived Prostate Cancer Vaccine CV9103

A prostate cancer vaccine containing mRNAs encoding prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), prostate stem cell antigen (PSCA) and six-transmembrane epithelial antigen of the prostate (STEAP), with potential antitumor activity. Upon administration, mRNA-derived prostate cancer vaccine CV9103 may stimulate the immune system to mount a cytotoxic T lymphocyte response (CTL) against PSA-, PSMA-, PSCA- and STEAP-expressing prostate tumor cells. The mRNA used in this vaccine is modified and formulated to have enhanced translational potency and adjuvant activities. PSA, PSMA, PSCA and STEAP may be upregulated in prostate cancer cells; their expression in prostate cancer has been correlated with disease progression. (NCI Thesaurus)

YOU MAY ALSO LIKE

mRNA-derived Lung Cancer Vaccine CV9202

A non-small cell lung cancer (NSCLC) vaccine containing six modified mRNAs, which encode six different NSCLC associated antigens, with potential antitumor and…

mRNA Transport Gene

An RNA transport gene that encodes a protein specifically involved in the transport of mRNA.

mRNA Surveillance

mRNA Surveillance works within elaborate cellular mechanisms to ensure accurate gene expression by assessing suitable mRNA quality for translation and prevents the…

mRNA Expression

The synthesis or transcription of messenger RNA.

mRNA Export

Transport of messenger RNA from its nuclear site of transcription to the cytoplasm, where the message is translated into protein by…

mRNA

A type of RNA found in cells. mRNA molecules carry the genetic information needed to make proteins. They carry the information…